Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.59−0.09 (-1.89%)
Close on Nov 17, 2026Market cap $63.91MP/E –Yield –
Champions Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Champions Oncology
Champions Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?